Latest News about Top Stories
Recent news which mentions Top Stories
Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System
November 20, 2024
From Benzinga
The Trade Desk Launches Ventura to Transform Streaming TV Advertising
November 20, 2024
From Benzinga
From Benzinga
Microsoft 'One Of The Most Compelling Investment Opportunities,' Says Goldman Sachs
November 20, 2024
From Benzinga
Stocks Fall Ahead Of Nvidia Earnings, Dollar Resumes Gains, Bitcoin Reaches New Record Highs: What's Driving Markets Wednesday?
November 20, 2024
From Benzinga
WeRide's Robotaxi And Partnerships Are Key Growth Drivers For Global Expansion: Analyst
November 20, 2024
From Benzinga
FDA Approves UCB's Psoriasis Drug For Expanded Use In Painful Inflammatory Skin Disease
November 20, 2024
From Benzinga
From Benzinga
Can Baidu Break Bearish Spell? Buying Pressure Shows Bullish Pre-Earnings Potential
November 20, 2024
From Benzinga
Nvidia Stock Historically Drops In December After Q3 Earnings
November 20, 2024
From Benzinga
Stock Of The Day: Delta Air Lines Bullish Pattern Suggests Upside Ahead
November 20, 2024
Tickers
DAL
From Benzinga
Palantir Tech's $140 Billion Market Cap Gain Is Driven By Trump's Victory And Higher Defense Spending Hope - Is The Stock Overvalued?
November 20, 2024
From Benzinga
Palo Alto Networks Navigates Bullish Trend, But May Be Ripe For Volatility Ahead Of Earnings
November 20, 2024
From Benzinga
Starfield Reaches 15 Million Players With Updates, New Content
November 20, 2024
From Benzinga
Snowflake Q3 Earnings: Will Bullish Charts, Analyst Optimism Offset The 32% YTD Decline?
November 20, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.